Marc Marien - Concepedia

Author

Marc Marien

Pierre Fabre (France)

Also Known As

MARC MARIEN, Marc Marien, Marc R Marien, Marc R. Marien

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Pierre Fabre (France)Inserm Centre National de la Recherche Scientifique Sorbonne Université Pitié-Salpêtrière Hospital

About

Marc Marien is an author at Pierre Fabre (France) specializing in medicine, neuropharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	23	1.1K
2	Social Sciences	12	12	723
3	Biochemistry	8	8	381
4	Health Sciences	3	3	135
5	Natural Sciences	3	3	77

Marc Marien

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Noradrenaline provides long‐term protection to dopaminergic neurons by reducing oxidative stress Jean‐Denis Troadec, Marc Marien, Frédéric Darios, Journal of Neurochemistry	2001	159
Time Course of Adaptations in Dopamine Biosynthesis, Metabolism, and Release Following Nigrostriatal Lesions: Implications for Behavioral Recovery from Brain Injury C. Anthony Altar, Marc Marien, John F. Marshall Journal of Neurochemistry	1987	159
Regional release of [<sup>3</sup>H]dopamine from rat brain <i>in vitro</i>: effects of opioids on release induced by potassium, nicotine, and <scp>L</scp>-glutamic acid Marc Marien, James F. Brien, Khem Jhamandas Canadian Journal of Physiology and Pharmacology	1983	127
Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis A. Lategan, Marc Marien, Françis C. Colpaert Brain Research Neurobiological MechanismNeurophysiologyNeuroanatomyNeurotransmitterEndogenous Dopamine	1990	120
Glutamate‐evoked release of endogenous brain dopamine: inhibition by an excitatory amino acid antagonist and an enkephalin analogue Khem Jhamandas, Marc Marien British Journal of Pharmacology	1987	110
Novelty Determines the Effects of Olfactory Enrichment on Memory and Neurogenesis Through Noradrenergic Mechanisms Alexandra Veyrac, Joëlle Sacquet, Véronique Nguyen, Neuropsychopharmacology Synaptic PlasticityNeuropsychologyCognitive ScienceNeurobiological MechanismDevelopmental Cognitive Neuroscience	2008	106
Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels Serge Guerreiro, Damien Toulorge, Étienne C. Hirsch, Molecular Pharmacology	2008	101
Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice Marc Marien, Mike Briley, Françis C. Colpaert European Journal of Pharmacology PsychopharmacologyNeuropharmacologyNoradrenaline DepletionNeuroscienceDopamine	1993	93
The Alpha2-Adrenoceptor Antagonist Dexefaroxan Enhances Hippocampal Neurogenesis by Increasing the Survival and Differentiation of New Granule Cells Pamela Rizk, Julio Salazar, Rita Raisman‐Vozari, Neuropsychopharmacology Developmental BiologyMedicineNeuroendocrine DisorderNeuroendocrine MechanismNeuropharmacology	2005	90
Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide Cristina Cosi, Marc Marien Brain Research BiochemistryMedicinePhysiologyMouse Brain Nad+Neuropharmacology	1998	87

Page 1